Apo Fenofibrate | Australian Register of Therapeutic Goods | Australia | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Apo Fenofibrate
Australia

European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Contact Supplier

Fenofibrate

Contact Supplier

Fenofibrate

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Fenofibrate

Contact Supplier

Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

Contact Supplier

Apo Fenofibrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

93 API Suppliers, 25 USDMF, 16 CEP/COS, 3 JDMF, 13 EU WC, 25 KDMF, 17 NDC API, 48 Listed Suppliers, $ API Reference Price

93 API Suppliers
25 USDMF
16 CEP/COS
3 JDMF
13 EU WC
25 KDMF
17 NDC API
48 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

347 FDF Dossiers, 133 FDA Orange Book, 93 Europe, 12 Canada, 34 Australia, 3 South Africa, 72 Listed Dossiers

347 FDF Dossiers
133 FDA Orange Book
93 Europe
12 Canada
34 Australia
3 South Africa
72 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 160MG, CAPSULE;ORAL - 100MG, CAPSULE;ORAL - 150MG, CAPSULE;ORAL - 50MG, TABLET;ORAL - 145MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 48MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 130MG, CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 43MG, CAPSULE;ORAL - 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 105MG, TABLET;ORAL - 35MG

TABLET;ORAL - 160MG
CAPSULE;ORAL - 100MG
CAPSULE;ORAL - 150MG
CAPSULE;ORAL - 50MG
TABLET;ORAL - 145MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 48MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 130MG
CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 43MG
CAPSULE;ORAL - 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 105MG
TABLET;ORAL - 35MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 1 PMC Isochem, 1 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 Kewpie Corporation, 14 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 3 Kirsch Pharma, 1 Panvo Organics, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 35 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 2 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 2 Esteem Industries, 2 Finar, 14 Gangwal Chemicals, 2 Gloria Interchem, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 3 Nanjing Bold Chemical, 1 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 31 Roquette, 15 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders, 52 Solubilizers, 49 Coating Systems & Additives, 49 Direct Compression, 48 Disintegrants & Superdisintegrants, 44 Thickeners and Stabilizers, 40 Granulation, 31 Taste Masking, 31 Controlled & Modified Release, 28 Topical, 26 Lubricants & Glidants, 23 Parenteral, 22 Chewable & Orodispersible Aids, 22 Film Formers & Plasticizers, 18 Emulsifying Agents, 16 Co-Processed Excipients, 10 API Stability Enhancers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 6 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents

76 Fillers, Diluents & Binders
52 Solubilizers
49 Coating Systems & Additives
49 Direct Compression
48 Disintegrants & Superdisintegrants
44 Thickeners and Stabilizers
40 Granulation
31 Taste Masking
31 Controlled & Modified Release
28 Topical
26 Lubricants & Glidants
23 Parenteral
22 Chewable & Orodispersible Aids
22 Film Formers & Plasticizers
18 Emulsifying Agents
16 Co-Processed Excipients
10 API Stability Enhancers
9 Empty Capsules
8 Surfactant & Foaming Agents
6 Rheology Modifiers
4 Vegetarian Capsules
2 Coloring Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 65 News #PharmaBuzz

2 Data Compilation #PharmaFlow
65 News #PharmaBuzz

GLOBAL SALES INFORMATION

61 US Medicaid Prescriptions, 38 Regulatory FDF Prices

61 US Medicaid Prescriptions
38 Regulatory FDF Prices

MARKET PLACE

27 APIs, 5 FDF Dossiers

27 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

16 US Patents, 10 Health Canada Patents

16 US Patents
10 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 9 Others

4 EDQM
4 USP
9 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 72 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

34 All

01 4Alphapharm Pty Ltd

02 4Apotex Pty Ltd

03 2Arrotex Pharmaceuticals Pty Ltd

04 4Cipla Australia Pty Ltd

05 4Generic Health Pty Ltd

06 4Sandoz Pty Ltd

07 4Sun Pharma ANZ Pty Ltd

08 4Viatris Pty Ltd

09 4WAGNER PHARMACEUTICALS PTY LTD

filter Active Ingredients Reset all filters

34 All

01 34Fenofibrate

filter Dosage Form Reset all filters

34 All

01 34tablet

filter Brand Name Reset all filters

34 All

01 4APO-Fenofibrate

02 2BTC Fenofibrate

03 4FENOFIBRATE RBX

04 4FENOFIBRATE-WGR

05 2Fenocol

06 4Fenofibrate Cipla

07 4Fenofibrate Lupin

08 2Fenofibrate Sandoz

09 4Fenofibrate Viatris

10 4Lipidil

List of Suppliers

Product Main Page

01

Alphapharm Pty Ltd

RNA Leaders Europe

Not Confirmed

Alphapharm Pty Ltd

RNA Leaders Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Fenofibrate

Brand Name : Fenofibrate Viatris

Dosage Form : tablet

Dosage Strength : 48 mg

Packaging : 60

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Alphapharm Pty Ltd

RNA Leaders Europe

Not Confirmed

Alphapharm Pty Ltd

RNA Leaders Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Fenofibrate

Brand Name : Fenofibrate Viatris

Dosage Form : tablet

Dosage Strength : 145 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Alphapharm Pty Ltd

Rare Disease Summit

Not Confirmed

Alphapharm Pty Ltd

Rare Disease Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Fenofibrate

Brand Name : Fenofibrate Viatris

Dosage Form : tablet

Dosage Strength : 48 mg

Packaging : 60

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Alphapharm Pty Ltd

Rare Disease Summit

Not Confirmed

Alphapharm Pty Ltd

Rare Disease Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Fenofibrate

Brand Name : Fenofibrate Viatris

Dosage Form : tablet

Dosage Strength : 145 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Apotex Pty Ltd

Rare Disease Summit

Not Confirmed

Apotex Pty Ltd

Rare Disease Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Fenofibrate

Brand Name : APO-Fenofibrate

Dosage Form : tablet

Dosage Strength : 48 mg

Packaging : 60

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Apotex Pty Ltd

RNA Leaders Europe

Not Confirmed

Apotex Pty Ltd

RNA Leaders Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Fenofibrate

Brand Name : APO-Fenofibrate

Dosage Form : tablet

Dosage Strength : 145 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Apotex Pty Ltd

RNA Leaders Europe

Not Confirmed

Apotex Pty Ltd

RNA Leaders Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Fenofibrate

Brand Name : APO-Fenofibrate

Dosage Form : tablet

Dosage Strength : 48 mg

Packaging : 60

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Apotex Pty Ltd

RNA Leaders Europe

Not Confirmed

Apotex Pty Ltd

RNA Leaders Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Fenofibrate

Brand Name : APO-Fenofibrate

Dosage Form : tablet

Dosage Strength : 145 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Arrotex Pharmaceuticals Pty Ltd

Rare Disease Summit

Not Confirmed

Arrotex Pharmaceuticals Pty Ltd

Rare Disease Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Fenofibrate

Brand Name : Fenocol

Dosage Form : tablet

Dosage Strength : 145 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Arrotex Pharmaceuticals Pty Ltd

Rare Disease Summit

Not Confirmed

Arrotex Pharmaceuticals Pty Ltd

Rare Disease Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Fenofibrate

Brand Name : Fenocol

Dosage Form : tablet

Dosage Strength : 145 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.